For decades, if a patient complained of persistent heartburn, regurgitation, or a chronic cough, the standard diagnostic pathway often led to one place: an endoscopy. This procedure, which involves passing a camera-tipped tube down the throat to examine the esophagus and stomach, has long been considered a cornerstone of reflux diagnosis. But it is invasive, expensive, and crucially it misses the majority of patients.

 

Endoscopy can only confirm reflux when it has already caused visible damage to the esophageal lining, such as erosions or Barrett's changes. In fact, studies show that endoscopy detects abnormalities in only about 30% of patients with gastroesophageal reflux disease (GERD). The remaining 70%—those with non‑erosive reflux disease (NERD)—receive a normal report despite suffering from significant symptoms ^[1]. For patients whose reflux reaches the throat, known as laryngopharyngeal reflux (LPR), endoscopy is even less useful, as the camera rarely extends high enough to assess the voice box or pharynx.

 

So, is there a simpler, non‑invasive way to find out whether reflux is truly the cause of your symptoms? The answer, increasingly, is yes—and it starts with a small saliva sample.

 

The Science Behind Saliva Testing

Reflux is not just about acid. The stomach produces a powerful digestive enzyme called pepsin, which breaks down proteins. Pepsin is unique to the stomach—it should never appear in saliva, throat secretions, or the airways under normal circumstances. When it does, it serves as a direct and objective biomarker that gastric contents have travelled upwards ^[2].

 

Pepsin testing works by detecting this enzyme in a patient’s saliva. Unlike endoscopy, which looks for secondary damage, pepsin testing identifies the root cause: the presence of stomach contents where they do not belong. This distinction is critical, particularly for patients with LPR, who often experience throat symptoms without ever feeling heartburn.

 

Clinical Evidence: How Accurate Is It?

A large multicenter study conducted in China validated the accuracy of Peptest—a laboratory‑based pepsin test—across nine hospitals, enrolling 1032 participants including 709 patients with confirmed GERD and 323 healthy controls. The results showed an overall sensitivity of 85%  for detecting reflux ^[1]. For patients with suspected LPR, a separate study found that Peptest Pepsin Detection achieved 100% specificity, meaning that a positive result was highly reliable in confirming the presence of reflux ^[3].

Now, Pepfast builds on this same proven technology. As a next‑generation version, it retains the core science, while introducing key innovations that make it simpler and faster for clinical use: no centrifugation, lab-free, and results in just 15 minutes. Designed for use under professional guidance, Pepfast has been clinically validated against Peptest with 100% concordance, meaning the same robust evidence applies.

 

How Does Saliva Testing Compare to Endoscopy?

The question is not whether a saliva test can replace endoscopy entirely—it cannot. Endoscopy remains essential for ruling out Barrett’s esophagus, strictures, and malignancies. However, for the vast majority of patients with uncomplicated reflux symptoms, a non‑invasive saliva test offers several advantages:

 

Feature	Endoscopy	Pepsin Saliva Test
Invasiveness	Invasive, requires intubation	Non-invasive, saliva only
Risk	Perforation, bleeding, sedation risks	None
Duration	1.5h	15 mins
Best for	Ruling out serious pathology	Confirming reflux as the cause
Access	Specialist center	Clinic or under professional guidance

 

 

For patients who are anxious about invasive procedures, or for whom endoscopy is not immediately indicated, a Mhrefluxcare saliva test can provide rapid, objective evidence to guide the next steps.

 

Who Might Benefit from a Saliva Test?

A non‑invasive reflux test is particularly valuable for:

• Patients with throat‑dominant symptoms: Hoarseness, chronic cough, globus sensation, or throat clearing—especially when heartburn is absent.
• Individuals continue to experience symptoms: A positive pepsin test can confirm that reflux is still occurring, even without visible esophageal damage.
• Those seeking to monitor treatment response: Repeating the test after lifestyle changes or medication can provide objective feedback on whether reflux is under control.
• Patients who are not candidates for invasive procedures: Due to age, comorbidities, or personal preference.

 

A Note on Pepfast and Professional Guidance

Pepfast Pepsin Detection Kit is a rapid, non‑invasive saliva test that detects pepsin without the need for centrifugation or laboratory equipment. It is designed to be used under the guidance of a healthcare professional, who can provide the test, instruct on sample collection, and interpret the results within the context of the patient’s full clinical picture. Results are available in approximately 15 minutes, enabling timely clinical decisions.

 

 

 

❓Frequently Asked Questions

1. Can a saliva test replace endoscopy for diagnosing reflux?
No. Endoscopy remains important for detecting precancerous changes and structural abnormalities. However, a saliva test can provide a simple, non‑invasive way to confirm whether reflux is occurring—particularly in patients with non‑erosive disease or throat‑dominant symptoms ^[1,3].

 

2. Is the saliva test easy to perform?
Yes. Pepfast requires a small saliva sample, applied to a lateral flow device. No centrifuge or special equipment is needed. Results are read visually within 15 minutes.

 

3. Can the test be used if I don’t have heartburn?
Absolutely. Pepsin testing is particularly useful for patients with extra‑esophageal symptoms such as chronic cough, hoarseness, or throat clearing—often called “silent reflux” ^[2,3].

 

4. How soon can I get results?
Pepfast provides a result in approximately 15 minutes from sample collection.

 

 

References

1. Wang YF, Yang CQ, Chen YX, et al. (2019). Validation in China of a non‑invasive salivary pepsin biomarker containing two unique human pepsin monoclonal antibodies to diagnose gastroesophageal reflux disease. Journal of Digestive Diseases, 20(6):278-287.

2. Li J, et al. (2024). Salivary pepsin testing for laryngopharyngeal reflux: will it change our management? Current Opinion in Otolaryngology & Head and Neck Surgery, 32(6):398-402.

3. Kucova I, et al. (2021). The Diagnostic Value of the Peptest in Detecting Laryngopharyngeal Reflux. Journal of Clinical Medicine, 10(16):3621.

 

That burning sensation in your chest after a spicy meal? That's classic heartburn, and it's hard to ignore. But what if your main complaint is a persistent tickle in your throat, a nagging cough, or the feeling of a lump that won't go away—without any burning sensation at all? You might be experiencing silent reflux, medically known as Laryngopharyngeal Reflux (LPR).

 

While both conditions stem from stomach contents traveling in the wrong direction, they affect different areas and present with vastly different symptoms. Understanding the difference is the first step toward finding the right answers. This article will clarify the distinct signs of heartburn and silent reflux, and explain why silent reflux is so often missed or misdiagnosed.

 

What is Heartburn?

Heartburn is not a disease itself, but a symptom—specifically, a burning sensation in the chest, just behind the breastbone. It typically occurs after eating, when lying down, or at night, and is caused by stomach acid flowing back into the esophagus.

 

This sensation is the most recognizable sign of acid reflux. It can last from a few minutes to several hours and is often described as a burning discomfort that moves up toward the throat. Occasional heartburn is common, but when it happens frequently, it may indicate an underlying condition such as Gastroesophageal Reflux Disease (GERD).

 

What is Silent Reflux (LPR)?

Silent reflux, or Laryngopharyngeal Reflux (LPR), is a condition where stomach contents—including acid and the digestive enzyme pepsin—travel all the way up past the esophagus, reaching the voice box (larynx) and the back of the throat (pharynx) ^[1].

 

It is called "silent" because it often occurs without the classic symptom of heartburn. Unlike the esophagus, the delicate tissues of the throat and voice box have no natural protection against acid or pepsin. Research has demonstrated that pepsin can damage the laryngeal and pharyngeal mucosa even at mild acidic or alkaline pH, showing some activity up to pH 8^[3]. This means irritation and damage can occur without any burning sensation in the chest.

 

Key Differences in Symptoms

The most significant difference lies in where the symptoms are felt. Heartburn is felt in the chest, while silent reflux symptoms are focused in the throat and voice. A study of 120 LPR patients found the most common symptoms to be throat irritation (58.3%), globus sensation (46%), dry cough (24%), and regurgitation (15%) ^[1].

 

Symptom	Heartburn	Silent Reflux
Primary Sensation	Burning in the chest	Throat irritation, tickling, or lump sensation
Voice	Usually unaffected	Hoarseness, voice changes, need to clear throat constantly
Cough	Less common	Chronic, dry cough
Swallowing	May have difficulty	Sensation of a lump in the throat
Mucus	Not a primary symptom	Excessive mucus or postnasal drip sensation
Taste	Sour or bitter taste in mouth	Bad or bitter taste possible

Many patients with LPR describe a feeling of a lump in their throat that won't go away, or they may find themselves constantly clearing their throat. One study found that globus sensation was the most common item in the Reflux Symptom Index, affecting 54% of pepsin-positive patients^[1]. Others report a sore throat that just never seems to heal.

 

The Diagnostic Challenge: Why "No Acid" Doesn't Mean "No Reflux"

This leads us to a common and frustrating question: "Why is my throat always sore but I feel no acid?" The answer is central to understanding LPR.

 

1. Silent Damage: The tissues of the larynx and pharynx are highly sensitive. Even a small amount of reflux—especially one containing the enzyme pepsin—can cause significant inflammation and symptoms. A systematic review published in the Journal of Voice found that salivary pepsin measurement for LPR diagnosis shows sensitivity ranging from 27.0% to 93.8% depending on the method and threshold used ^[2]. You don't need a large, acidic "event" to feel the effects.

 

2. Atypical Presentation: Many people with LPR do not have the classic heartburn symptoms. They are sometimes referred to as having "silent reflux" because the reflux itself is silent, even though its effects on the throat are quite noticeable. According to recent reviews, extraesophageal reflux presents with laryngopharyngeal symptoms including chronic cough and vocal changes ^[4].

 

About Maxhealth Innovative Meditech

If you'd like to learn more about the science behind reflux testing and treatment, Maxhealth Innovative Meditech is an innovative provider of complete solutions for reflux disease—from non‑invasive diagnostics to physical barrier therapies. Visit our page to see how we're advancing reflux care worldwide.

 

❓Frequently Asked Questions

1. What are the most common LPR symptoms?

The most common symptoms include throat irritation (58.3%), globus sensation (46%), chronic cough (24%), regurgitation (15%), hoarseness, and excessive throat clearing [1]. Unlike heartburn, chest burning is often absent.

 

2. Why is silent reflux called "silent"?

It is called "silent" because it often occurs without heartburn—the most recognizable symptom of acid reflux. The reflux happens without the person feeling the classic burning sensation, even though it is causing damage to the throat and voice box [4].

 

3. Why is my throat always sore but I feel no acid?

This is a hallmark of LPR. The stomach enzyme pepsin, not just acid, can damage the delicate lining of your throat. Research has shown that pepsin can damage laryngeal mucosa even at mild acidic or alkaline pH [3]. You may not feel the actual reflux event, but the presence of pepsin can cause persistent inflammation, soreness, and irritation.

 

4. Can you have both heartburn and silent reflux?

Yes, it is possible to have both conditions. Some people with GERD also develop LPR, as stomach contents can travel all the way up to the throat. However, many people with LPR never experience heartburn [4].

 

5. When should I see a doctor about my symptoms?

If you have persistent throat discomfort, hoarseness, chronic cough, or a feeling of a lump in your throat that doesn't go away, it's worth consulting an ENT specialist. They can help determine whether silent reflux or another condition is causing your symptoms.

 

Literature References

[1] Divakaran S, Manimaran V, Shetty S, et al. (2020). Laryngopharyngeal Reflux: Symptoms, Signs, and Presence of Pepsin in Saliva - A Reliable Diagnostic Triad. International Archives of Otorhinolaryngology, 25(2): e273-e278.

[2] Hiernaux A, et al. (2025). Salivary Pepsin Measurement in Laryngopharyngeal Reflux Disease: A Systematic Review of Diagnostic Accuracy and Performance. Journal of Voice, S0892-1997(25)00332-7.

[3] Li J, et al. (2024). Salivary pepsin testing for laryngopharyngeal reflux: will it change our management? Current Opinion in Otolaryngology & Head and Neck Surgery, 32(6):398-402.

[4] Blaine-Sauer S, et al. (2025). Extraesophageal reflux: Clinical manifestations and tools for diagnosis and treatment. Annals of the New York Academy of Sciences, 1547(1):233-244.

 

Medical Review by: Prof. Peter Dettmar, world-renowned expert in reflux disease and the original developer of pepsin detection technology.

 

Gastroesophageal reflux disease (GERD) is one of the most prevalent chronic gastrointestinal disorders which affects nearly 20% population worldwide, with diverse and non-specific symptoms that create significant diagnostic challenges. Traditional diagnostic methods, including symptom questionnaires, PPI trials, endoscopy, and impedance-pH monitoring, are often limited by invasiveness, low specificity, or complex operation. Pepfast is a novel saliva-based lateral flow in vitro diagnostic device for the qualitative detection of pepsin, providing a non-invasive, rapid, and objective auxiliary approach for the clinical assessment of GERD. This article briefly introduces the scientific basis of pepsin as a reflux biomarker, the operating procedure and clinical value of Pepfast.

 

Introduction to Pepfast

Pepfast is a pepsin detection device lauched by Maxhealth Innovative Meditech based on UK core technology, dedicated to the auxiliary diagnosis of gastroesophageal reflux disease. It uses highly specific human monoclonal antibodies against pepsin and can obtain clear results within 15 minutes. The device does not require centrifugation or other laboratory equipment, which simplifies the clinical operation process while maintaining high diagnostic accuracy and reliability.

 

Pepfast has obtained NMPA Class II certification, CE marking and FDA clearance, and is suitable for use in gastroenterology, otorhinolaryngology, respiratory medicine and primary care institutions. Clinical verification shows that it has good consistency and diagnostic performance, and can be operated by patients under clinical guidance to ensure standardized operation and reliable results.

 

Pepsin as a Specific Biomarker for Reflux-Related Diseases

Pepsin is a proteolytic enzyme uniquely produced by gastric chief cells. Its presence in the esophagus, pharynx, or oral cavity indicates the occurrence of gastroesophageal reflux, making it a specific objective biomarker for reflux events ^[1].

 

A clinical study by Hayat et al. (2015) confirmed that salivary pepsin testing can effectively distinguish patients with reflux-related symptoms from those with functional heartburn, providing high-level clinical evidence for the diagnostic value of pepsin ^[1].

 

Operational Procedure of Pepfast

Pepfast is simple to operate and does not rely on laboratory instruments. Before sampling, individuals should avoid eating, carbonated drinks or smoking which will trigger reflux for at least 60 minutes to ensure sample validity.

 

After collecting saliva and mix it with the migration buffer, the mixed solution is directly added to the test kit, and the result can be read after 15 minutes. A single control line indicates a negative result, showing the patient was not refluxing at the time sample was collected; while both test line and control line indicate a positive result which shows the patient is refluxing gastric content and can be treated for reflux; no control line indicates an invalid test and needs to be repeated.

Clinical Value of Pepfast

Pepfast provides a standardized, non-invasive, and rapid auxiliary diagnostic solution for GERD, helping clinicians objectively confirm reflux events and reduce diagnostic bias caused by subjective symptom reports. It is particularly valuable in the initial screening of suspected reflux patients, differentiation between reflux-related symptoms and functional heartburn, and reduction of unnecessary invasive examinations and prolonged empirical PPI therapy. With reliable performance and simplified operation, Pepfast optimizes the clinical management pathway for GERD and promotes precise and personalized intervention for patients with suspected reflux.

 

References

1. Hayat JO, Gabieta-Somnez S, Yazaki E, et al. Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease. Gut. 2015; 64: 373–380.

 

❓Frequently Asked Questions

1. Who can perform the Pepfast test?

Pepfast can be operated by doctors as well as patients under clinical guidance to ensure standardized operation and reliable results.

 

2. How long is the Pepfast result valid after the test is performed?

The result appears within 15 minutes and should be read during this window. If more than 30 minutes have passed, the result is considered invalid. Please read the result within the specified timeframe for accurate interpretation.

 

3. Is there any age restriction for using Pepfast?

There is no specific age restriction. However, for infants and young children who are unable to spit on their own, a healthcare professional may need to collect the sample using a straw or aspirator. For elderly individuals, saliva may be thicker—please avoid collecting samples that contain sputum to ensure accurate results.

 

 

For years, diagnosing laryngopharyngeal reflux (LPR)—often called silent reflux—has been a challenge. Symptoms such as chronic cough, hoarseness, throat clearing, and a sensation of a lump in the throat can overlap with allergies, sinusitis, or voice disorders. Traditional diagnostic methods, including flexible laryngoscopy and 24‑hour multichannel intraluminal impedance-pH monitoring, are invasive, time‑consuming, and not always accessible in routine clinical settings.

 

That is why a growing number of medical professionals are turning to Peptest, a simple, non‑invasive saliva test that detects pepsin—a direct biomarker of gastric reflux. Peptest is now used in hospitals and clinics across multiple specialties, providing objective evidence to support diagnosis and treatment decisions.

 

What the Research Shows

Multiple clinical studies have validated Peptest as a reliable screening tool for reflux disease. A study published in the Journal of Clinical Medicine evaluated Peptest in patients with suspected LPR and found that it demonstrated 100% specificity in detecting the condition, outperforming non‑invasive methods such as the Reflux Symptom Index (RSI) and Reflux Finding Score (RFS). The researchers concluded that a positive Peptest result is “highly supportive of a pathological LPR diagnosis” and noted its value as a screening test for physicians who cannot visualize the larynx, particularly in the context of COVID‑safe, non‑invasive procedures ^[1].

 

In China, a large multicenter study published in the Journal of Digestive Diseases further validated Peptest’s clinical utility. The study enrolled 1032 participants across nine hospitals in Shanghai and Beijing, including 488 patients with non‑erosive reflux disease (NERD), 221 with erosive esophagitis (EE), and 323 healthy controls. The results showed an overall pepsin‑positive sensitivity of 85% ^[2]. The study concluded that Peptest provides a rapid, non‑invasive alternative to traditional diagnostic methods and improves the accuracy of reflux diagnosis, particularly in a population where reflux disease has been underdiagnosed due to a lack of effective objective tests ^[2].

 

Together, these studies demonstrate that Peptest is a valuable tool across different populations and clinical settings, offering a simple, painless way to confirm or rule out reflux.

 

Which Specialties Can Benefit from Peptest?

Peptest is designed to support clinicians across a range of disciplines where reflux plays a hidden but significant role.

1. Ear, Nose and Throat (ENT) Specialists

ENT clinicians regularly see patients with hoarseness, globus sensation, throat clearing, and chronic cough—all potential signs of LPR. Peptest offers a quick, objective way to confirm reflux as the underlying cause, helping to differentiate it from other laryngeal conditions.

2. Gastroenterologists

For gastroenterologists managing patients with gastro‑esophageal reflux disease (GERD), Peptest provides a non‑invasive tool to assess whether reflux is reaching the upper airway. It can also be used to monitor treatment response in patients with persistent symptoms despite acid suppression.

3. General Practitioners (GPs) and Primary Care

GPs are often the first point of contact for patients with reflux symptoms. With Peptest, they can obtain objective evidence early, guiding appropriate referrals and avoiding unnecessary or prolonged use of acid‑suppressing medication before a confirmed diagnosis.

4. Pulmonologists and Chest Physicians

Chronic cough is a common extra‑esophageal manifestation of reflux. Peptest helps pulmonologists identify reflux as a contributor to persistent cough, potentially reducing unnecessary investigations for other causes.

5. Allergists

Symptoms such as throat irritation and post‑nasal drip can mimic allergies. Peptest enables allergists to rule out reflux when the diagnosis is uncertain, or to identify it as a coexisting condition requiring separate management.

 

Peptest in China: A Trusted Solution Since 2019

Peptest was first developed in the UK and has been used clinically for over 15 years. In 2019, it received NMPA registration, marking a significant step in making non‑invasive reflux testing accessible to Chinese patients and clinicians.

 

Maxhealth Innovative Meditech serves as the exclusive distributor of Peptest in China, working closely with hospitals and healthcare providers to integrate this innovative diagnostic tool into routine practice. To learn more about the launch and our ongoing commitment to reflux care, read our company news here.

 

Why Early Diagnosis Matters

An early, objective diagnosis of reflux opens the door to targeted management—whether that involves lifestyle modification, dietary changes, physical barrier therapies such as alginates, or, where appropriate, acid suppression. Peptest can also be used after treatment to assess whether reflux has been successfully controlled, providing a valuable endpoint that goes beyond symptom reporting ^[1].

 

For patients, the benefits are clear: a painless test that delivers clear answers. For clinicians, Peptest offers a practical, evidence‑based tool that fits seamlessly into modern practice.

 

❓Frequently Asked Questions

1. How accurate is Peptest for detecting LPR?
In a published study, Peptest demonstrated 100% specificity in a group of patients with suspected LPR ^[1]. A large Chinese multicenter study reported an overall sensitivity of 85% for detecting GERD ^[2].

2. Is Peptest available in China?
Yes. Peptest received NMPA registration in 2019 and is distributed exclusively by Maxhealth. It is used in hospitals and clinics across the country.

3. Can Peptest be used to monitor treatment?
Yes. Peptest can be repeated during or after treatment to provide objective evidence of whether reflux is adequately controlled ^[1].

4. How does Peptest compare to endoscopy or pH monitoring?
Peptest is non‑invasive, requires no special equipment or lengthy procedures, and detects the presence of pepsin—a direct biomarker of reflux. It complements traditional methods by offering a simple, patient‑friendly screening option.

 

References

1. Kucova I, et al. (2021). The Diagnostic Value of the Peptest in Detecting Laryngopharyngeal Reflux. Journal of Clinical Medicine, 10(16):3621.

2. Wang YF, Yang CQ, Chen YX, et al. (2019). Validation in China of a non‑invasive salivary pepsin biomarker containing two unique human pepsin monoclonal antibodies to diagnose gastroesophageal reflux disease. Journal of Digestive Diseases, 20(6):278-287.

 

Medical Review by: Prof. Peter Dettmar, world‑renowned expert in reflux disease and the original developer of pepsin detection technology.

If you’ve been living with a persistent cough, hoarseness, throat clearing, or heartburn, you’ve probably wondered: Is there a test that can tell me if reflux is the cause—without an endoscopy or a tube down my nose? The good news is yes. A non‑invasive reflux test that detects the stomach enzyme pepsin in your saliva is now available. The even better news is that you don’t need to be in a hospital to get one. In many countries, you can obtain a Pepfast Pepsin Detection Kit through your doctor, a clinic, or even a pharmacy—thanks to the presence of trained pharmacists who can provide professional guidance.

 

This article explains exactly where and how you can access a reliable, medical‑grade reflux test, why professional oversight is a benefit (not a barrier), and how the process compares to traditional invasive diagnostics.

 

What Is a Pepsin Reflux Test and Why Is It Different?

Pepsin is a digestive enzyme produced only in your stomach. Under normal circumstances, it should never appear in your saliva. When it does, it is a direct biomarker that gastric contents have refluxed into your throat or airways. Unlike endoscopy, which looks for secondary damage, a pepsin test identifies the root cause: the presence of stomach contents where they don’t belong ^[1].

 

The Pepfast Pepsin Detection Kit uses lateral flow technology—similar to a rapid pregnancy test—to detect pepsin in a small saliva sample. It requires no tubes, no scopes, no sedation, and no centrifugation. Results appear in just 15 minutes.

 

Where Can You Get a Pepfast Pepsin Detection Kit? (Three Options)

Because Pepfast Pepsin Detection Kit is a regulated medical device, it is not sold over the counter like a candy bar. However, it is widely accessible through three professional channels.

 

1. Your Doctor (GP, ENT, or Gastroenterologist)

This is the most common route. You describe your symptoms—heartburn, regurgitation, chronic cough, hoarseness, lump sensation in the throat. If your doctor suspects reflux (especially LPR, the “silent” type), they can prescribe or provide you with a Pepfast kit. You take it home, collect a saliva sample in minutes, read the result in 15 minutes, and then discuss the outcome with your doctor to plan next steps.

 

2. A Hospital or Outpatient Clinic

Many gastroenterology or ENT clinics now stock pepsin tests as a first‑line screening tool. During your visit, a nurse or clinician may hand you the kit, explain the simple instructions, and have you collect the sample on‑site or at home. Results are then integrated into your clinical record.

 

3. A Pharmacy (with a Pharmacist)

In many countries, such as the UK, Germany, Australia, and parts of the US—pharmacists are trained healthcare professionals who can assess your symptoms, provide professional advice, and supply certain medical devices without a doctor’s prescription. This includes the Pepfast Pepsin Detection Kit. You can walk into a participating pharmacy, speak with the pharmacist about your reflux symptoms, and if appropriate, they will give you the kit, explain how to use it, and help you interpret the result. The pharmacist may also recommend follow‑up with a doctor if the result is positive or if symptoms persist.

 

Note: In some regions, you may need a prescription. Always check local regulations. The key point is that a trained professional—doctor or pharmacist—is involved to ensure correct use and interpretation.

 

Why Professional Guidance Is a Benefit, not a Hassle

Some people think, “Why can’t I just buy this online and do it completely alone?” The answer lies in clinical accuracy. A 2019 multicenter study in China involving over 1000 participants found that the pepsin test had a sensitivity of 85% for GERD ^[1]. For LPR, another study reported 100% specificity ^[2]. But no test is perfect. A false positive could lead to unnecessary medication; a false negative might delay treatment for another condition.

 

A professional—whether a doctor or a pharmacist—helps you:

• Decide if the test is appropriate for your symptoms.
• Ensure you collect the sample correctly (though the instructions are simple).
• Interpret the result in the context of your medical history.
• Recommend the next steps: lifestyle changes, physical barrier therapy (like alginates), acid suppression, or further testing.

 

Compare that to traditional reflux diagnostics:

• Endoscopy: fasting, sedation, a camera down your throat, recovery time.
• 24‑hour pH monitoring: a thin tube through your nose, worn for a full day, disrupting sleep and work.

 

With Pepfast pepsin detection kit, you spend a few minutes talking to a professional, then collect saliva at home. No sedation. No tubes. No missed work. The “professional step” is tiny compared to the invasiveness of older methods.

 

Why This Matters for Patients and for Distributors

For patients: You now have a simple, non‑invasive way to get objective evidence about whether reflux is causing your symptoms. The process is faster and far more comfortable than traditional testing.

 

For distributors and pharmacies: The growing demand for convenient reflux testing represents a significant market opportunity. Products like Pepfast, which are regulatory‑cleared (CE, FDA, NMPA) and designed for professional guidance, can be stocked by pharmacies and clinics. Pharmacists can offer the test as a value‑added service, helping patients get answers without a hospital visit. This aligns with the global shift toward community‑based, accessible diagnostics.

 

Introducing Pepfast: The Clinician‑Guided, Patient‑Friendly Test

Pepfast is a non‑invasive saliva test launched by Maxhealth Innovative Meditech that detects pepsin without centrifugation. It delivers results in 15 minutes and is intended for use under professional guidance—from a doctor, clinic, or pharmacist. With CE, FDA, and NMPA clearances, Pepfast is ready for distribution worldwide. It offers a simple, objective way to confirm reflux, enabling faster, more confident treatment decisions.

• For patients: Ask your doctor or local pharmacist about Pepfast.
• For pharmacies and distributors: Contact Mhrefluxcare for product specifications, and partnership opportunities.

 

❓Frequently Asked Questions

1. Can I buy a reflux test at a pharmacy without a prescription?

In many countries (e.g., UK, Germany, Australia), trained pharmacists can supply Pepfast pepsin detection kit after a brief consultation to ensure it’s appropriate for your symptoms. In other regions, a prescription may be required. Check with your local pharmacy.

 

2. What do the results mean?

Two lines = positive (pepsin detected, suggesting reflux). One C line = negative (no pepsin detected at this time). No line=invalid (need to repeat the test). Your healthcare professional will interpret the result alongside your symptoms.

 

3. How accurate is Pepfast pepsin detection kit?

Clinical studies report sensitivity of 85% for GERD and up to 100% specificity for LPR [1,2]. The test is a reliable screening tool when used under professional guidance.

 

4. Can I use Pepfast if I have throat symptoms but no heartburn?

Absolutely. Pepfast is especially useful for LPR (“silent reflux”), which often presents as hoarseness, chronic cough, throat clearing, or a lump sensation without heartburn.

 

 

Reference

[1] Wang YF, Yang CQ, Chen YX, et al. (2019). Validation in China of a non‑invasive salivary pepsin biomarker containing two unique human pepsin monoclonal antibodies to diagnose gastroesophageal reflux disease. Journal of Digestive Diseases, 20(6):278-287.

[2] Kucova I, et al. (2021). The Diagnostic Value of the Peptest in Detecting Laryngopharyngeal Reflux. Journal of Clinical Medicine, 10(16):3621.

 

Medical Review by: Prof. Peter Dettmar, world‑renowned expert in reflux disease and the original developer of pepsin detection technology.

自1986年以来，SINCE展会已成功举办，涵盖了无纺布产业链的全过程。随着中国经济改革的步伐和无纺布产业的蓬勃发展，SINCE已发展成为亚洲地区重要且具有影响力的行业盛会。2025年12月3日至5日，合肥泰利杰卫生材料有限公司将携全系列产品亮相SINCE展会，并展示其在产品研发、生产制造和质量控制方面的综合实力和创新成果。

在本次展会上，泰利杰重点展示了其适用于各种应用场景的可水洗纸，同时还展出了床单卷、围兜、各类无纺布产品以及定制解决方案，充分展现了公司在卫生材料领域深厚的技术积累和持续创新能力。展会期间，泰利杰团队通过样品演示、技术讲解和一对一洽谈等方式，与众多客户进行了精准沟通。基于技术创新和服务升级，泰利杰为客户提供了更具针对性的产品匹配方案和优质的售前售后服务。

每一届SINCE都是行业关注和思想交流的重要平台；泰利杰已连续多年参加该展会，不仅展示了公司在卫浴材料领域的强大积累，而且通过与新老客户、供应商和行业专家的真诚交流，把握了行业最新趋势和合作机遇，促进了技术合作和业务拓展。

通过此次展会，泰利杰进一步巩固了国内外合作基础，并通过与行业伙伴的深入交流，更好地把握了国际市场的新趋势。未来，公司将继续加大研发投入，推进绿色生产和可持续材料应用，推动产品向高端化、差异化、多元化方向发展；同时，我们将强化数字化生产和服务能力，优化全球供应链和客户支持体系，以领先的技术和高端产品服务全球客户，不断提升品牌在全球卫浴材料市场的影响力和市场份额，为行业的健康可持续发展做出贡献。

In modern hospitals, efficiency directly affects patient care. Medical carts are no longer simple transport tools—they function as mobile nursing stations, emergency support units, and workflow assistants used throughout the day. Choosing the right medical cart helps improve staff efficiency, reduce physical strain, and support infection control standards.

 This guide outlines the key factors hospitals should consider when selecting medical carts, focusing on materials, design features, and supplier capabilities.

 

Medical Cart Materials: Why Lightweight Aluminum Matters

Traditionally, stainless steel has been widely used for medical carts due to its strength and durability. However, daily hospital operations require staff to push carts over long distances, making weight an important consideration—especially for carts used frequently, such as mobile medical medication cart systems in wards and pharmacies.

Aerospace-grade aluminum alloy is increasingly preferred because it is significantly lighter while still offering excellent load-bearing capacity and impact resistance. This reduces physical strain on medical staff and improves maneuverability in busy corridors. In addition, aluminum naturally resists corrosion and rust, making cleaning and disinfection easier—an essential factor for maintaining infection control standards. Its smooth surface and modern appearance also contribute to a cleaner, more professional hospital environment.

 

Medical Cart Design Features That Improve Daily Use

Beyond materials, practical design details determine how well a medical cart performs in real hospital scenarios.

High-quality wheels should move smoothly and quietly, especially in wards where minimizing noise is important for patient comfort. Reliable braking systems are equally critical, allowing carts to remain stable during procedures or urgent situations, such as when using a medical emergency cart in fast-paced clinical environments.

Adjustable handle heights help accommodate staff of different statures, reducing fatigue during long shifts. Modular design is another key factor. Carts that allow drawers, baskets, and accessory holders to be added or removed can be adapted to the needs of different departments, improving usability and extending product lifespan.

 

Choosing a Medical Cart Supplier: Brand, Service, and Customization

Selecting a medical cart is not just about the product itself, but also about the supplier’s understanding of clinical workflows. Hospitals increasingly rely on solutions like a mobile clinical workstation, which combines storage, mobility, and digital support into a single platform.

Manufacturers that focus on ergonomic design, lightweight structures, and modular configurations are better positioned to meet these evolving needs. Some suppliers, such as Likaymo, emphasize aluminum-based structures combined with customizable layouts, allowing carts to be adapted for emergency care, anesthesia, or routine nursing tasks. The ability to provide customization and long-term support ensures that carts integrate smoothly into daily operations rather than becoming fixed, one-size-fits-all tools.

 

Matching Medical Carts to Different Hospital Departments

Different departments often prioritize different cart features:

l Emergency departments: high mobility, stable braking systems, modular storage

l Nursing stations: ergonomic handles, quiet wheels, organized drawers

l Procedure and anesthesia rooms: easy-to-clean surfaces and customized configurations

Choosing carts based on real usage scenarios helps maximize efficiency and safety.

Focus on Practical Needs and Long-Term Value

 

Selecting medical carts is a long-term investment in workflow efficiency, staff well-being, and patient safety. Rather than focusing solely on price or traditional materials, hospitals should consider lightweight construction, user-centered design, and the supplier’s ability to adapt carts to specific clinical environments.

By choosing medical carts based on actual operational needs, hospitals can build more efficient, flexible, and sustainable care systems.If you would like to learn more, please visit our website：www.likaymo.com

In the fast-paced healthcare environment, traditional workflows face significant challenges. Nursing staff walk an average of several kilometers per shift, with a substantial portion of their time consumed by information transfer and locating supplies. This inefficient model is driving the demand for innovative smart mobile workstation solutions.

 

Three Major Bottlenecks of Traditional Work Models

Information Delay Challenges
Paper-based medical record systems lead to delayed information updates, hindering clinical collaboration and often causing critical decision-making to be obstructed by information asymmetry.

 

Equipment Fragmentation Issues
Monitoring devices, computer terminals, medications, and consumables require multiple carts for transport, not only occupying space but also increasing operational complexity.

 

Separation of Staff from Technology
Fixed workstations force healthcare providers to repeatedly leave the patient's bedside, consuming valuable treatment time with unnecessary movement.

 

Core Advancements of Intelligent Solutions

Integrated Information Hub
Modern solutions represented by the Likaymo OS-6 Smart All-in-One Station integrate medical-grade touchscreen computer systems, enabling seamless direct connection with HIS/EMR systems. Its high-definition anti-glare touchscreen supports various operational environments, ensuring that information review, order execution, and real-time documentation can be completed at the bedside.

 

Continuous Power Security System
The device features a built-in intelligent UPS uninterruptible power supply, providing a critical operational window during sudden power outages to ensure data security and proper device shutdown. The smart battery management system supports extended continuous operation.

The Evolution of Smart Healthcare

Forward-thinking hospitals are already utilizing platforms like Likaymo OS-6 to achieve:

• IoT Integration: Automatic association of patient information through RFID technology

• Intelligent Decision Support: Real-time alert systems based on clinical guidelines

• Remote Collaboration: High-definition consultations and expert guidance over 5G networks

The core of healthcare digital transformation lies in integrating intelligent technology into workflows.The Likaymo OS-6 Smart All-in-One Mobile Workstation truly realizes the concept of "bringing the workstation to the patient's bedside" through triple innovation in hardware integration, software connectivity, and power security. This represents not merely a tool upgrade but a fundamental advancement in healthcare service delivery models.

 

If you would like to learn more, please visit our website: www.likaymo.com